In addition, they also reported new quinazoline-urea based compounds with potent cytotoxic activities against TMZ-resistant glioblastoma multiforme (GBM) cells, which may be associated with plausible binding modes in translocator protein 18 kDa (TSPO). The gene discussed is TSPO; the disease is glioblastoma.